CN111499699A - 一种新型冠状病毒covid-19-n蛋白表达和纯化的方法 - Google Patents
一种新型冠状病毒covid-19-n蛋白表达和纯化的方法 Download PDFInfo
- Publication number
- CN111499699A CN111499699A CN202010481504.5A CN202010481504A CN111499699A CN 111499699 A CN111499699 A CN 111499699A CN 202010481504 A CN202010481504 A CN 202010481504A CN 111499699 A CN111499699 A CN 111499699A
- Authority
- CN
- China
- Prior art keywords
- protein
- covid
- culture
- purifying
- centrifuging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010481504.5A CN111499699A (zh) | 2020-05-31 | 2020-05-31 | 一种新型冠状病毒covid-19-n蛋白表达和纯化的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010481504.5A CN111499699A (zh) | 2020-05-31 | 2020-05-31 | 一种新型冠状病毒covid-19-n蛋白表达和纯化的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111499699A true CN111499699A (zh) | 2020-08-07 |
Family
ID=71872226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010481504.5A Pending CN111499699A (zh) | 2020-05-31 | 2020-05-31 | 一种新型冠状病毒covid-19-n蛋白表达和纯化的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111499699A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112225781A (zh) * | 2020-09-03 | 2021-01-15 | 清源生物(深圳)有限公司 | 一种高效表达新型冠状病毒n蛋白的方法 |
CN112812156A (zh) * | 2021-04-02 | 2021-05-18 | 厦门宝太生物科技有限公司 | 一种新型冠状病毒covid-19-s1蛋白的表达和纯化方法 |
CN113372430A (zh) * | 2021-06-09 | 2021-09-10 | 南京欧凯生物科技有限公司 | 涎液化糖链抗原-6及其制备方法 |
CN113666988A (zh) * | 2021-07-07 | 2021-11-19 | 上海裕隆生物科技有限公司 | 新型冠状病毒核衣壳蛋白n端结构域的制备方法及应用 |
WO2022089550A1 (en) * | 2020-10-28 | 2022-05-05 | Jiangsu Code Biomedical Technology Co., Ltd. | Novel compositions and methods for coronavirus detection |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1472318A (zh) * | 2003-06-02 | 2004-02-04 | 中国科学院上海药物研究所 | 可溶性sars病毒核衣壳蛋白的表达和纯化 |
CN104561022A (zh) * | 2014-12-22 | 2015-04-29 | 南京师范大学 | 家猪肿瘤坏死因子突变体的构建及蛋白表达纯化方法 |
CN110669141A (zh) * | 2019-09-29 | 2020-01-10 | 杭州联科生物技术股份有限公司 | 一种别藻蓝蛋白(APC)与Annexin V蛋白偶联方法 |
CN111153991A (zh) * | 2020-02-26 | 2020-05-15 | 北京博奥森生物技术有限公司 | 一种人SARS-CoV-2单克隆抗体及其制备方法和应用 |
CN111187354A (zh) * | 2020-02-20 | 2020-05-22 | 北京新创生物工程有限公司 | 新型冠状病毒(SARS-CoV-2)IgM/IgG抗体检测试剂盒 |
-
2020
- 2020-05-31 CN CN202010481504.5A patent/CN111499699A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1472318A (zh) * | 2003-06-02 | 2004-02-04 | 中国科学院上海药物研究所 | 可溶性sars病毒核衣壳蛋白的表达和纯化 |
CN104561022A (zh) * | 2014-12-22 | 2015-04-29 | 南京师范大学 | 家猪肿瘤坏死因子突变体的构建及蛋白表达纯化方法 |
CN110669141A (zh) * | 2019-09-29 | 2020-01-10 | 杭州联科生物技术股份有限公司 | 一种别藻蓝蛋白(APC)与Annexin V蛋白偶联方法 |
CN111187354A (zh) * | 2020-02-20 | 2020-05-22 | 北京新创生物工程有限公司 | 新型冠状病毒(SARS-CoV-2)IgM/IgG抗体检测试剂盒 |
CN111153991A (zh) * | 2020-02-26 | 2020-05-15 | 北京博奥森生物技术有限公司 | 一种人SARS-CoV-2单克隆抗体及其制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
徐小静,等: "《生物技术原理与实验》", 31 July 2006, 北京:中央民族大学出版社 * |
蒋达和,等: "《生物化学实验指导》", 31 August 2011, 武汉:武汉大学出版社 * |
鞠守勇: "新型冠状病毒(SARS-CoV-2)核衣壳蛋白(N蛋白)的表达研究", 《武汉职业技术学院学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112225781A (zh) * | 2020-09-03 | 2021-01-15 | 清源生物(深圳)有限公司 | 一种高效表达新型冠状病毒n蛋白的方法 |
WO2022089550A1 (en) * | 2020-10-28 | 2022-05-05 | Jiangsu Code Biomedical Technology Co., Ltd. | Novel compositions and methods for coronavirus detection |
CN112812156A (zh) * | 2021-04-02 | 2021-05-18 | 厦门宝太生物科技有限公司 | 一种新型冠状病毒covid-19-s1蛋白的表达和纯化方法 |
CN113372430A (zh) * | 2021-06-09 | 2021-09-10 | 南京欧凯生物科技有限公司 | 涎液化糖链抗原-6及其制备方法 |
CN113666988A (zh) * | 2021-07-07 | 2021-11-19 | 上海裕隆生物科技有限公司 | 新型冠状病毒核衣壳蛋白n端结构域的制备方法及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111499699A (zh) | 一种新型冠状病毒covid-19-n蛋白表达和纯化的方法 | |
CN105755025B (zh) | 一种重组蛛丝蛋白的制备方法 | |
CN110964096B (zh) | 一种重组人源c反应蛋白的制备方法 | |
KR101650869B1 (ko) | 엔지니어링 박테리아 재조합 단백질의 고효율 발현방법 및 응용 | |
CN104725517A (zh) | 一种提高酵母细胞表面目的蛋白展示量的方法 | |
CN114657113A (zh) | 一种表达全能核酸酶的重组菌及其应用 | |
CN111979214A (zh) | Sars主蛋白酶的表达和纯化方法 | |
CN105420174A (zh) | 一种表达重组vegf融合蛋白的基因工程菌的构建 | |
CN109134620A (zh) | 一种纯化HBc-VLPs或HBc-VLPs衍生物的方法 | |
CN112646044B (zh) | TFF2-Fc融合蛋白及其高效表达生产方法 | |
CN103740632B (zh) | 一株重组大肠杆菌及其在制备抗o157:h7的n-糖蛋白疫苗中的应用 | |
CN112111496A (zh) | 稀有鮈鲫载脂蛋白ApoE基因、重组蛋白、多克隆抗体及制备方法和应用 | |
CN107083375B (zh) | 一种中温α-淀粉酶及其基因和应用 | |
CN110904139A (zh) | 重组载体、菌株、水稻纹枯病菌效应蛋白的表达纯化方法 | |
CN110777138A (zh) | 一种利用gem去除重组蛋白内毒素的方法 | |
CN114044816B (zh) | 重组长牡蛎焦孔素蛋白rCgGSDME-N、制备方法及其应用 | |
CN102703490B (zh) | 重组链霉亲和素的制备工艺 | |
CN113372428B (zh) | 文昌鱼C型凝集素BjCTL4基因及其应用 | |
CN116425853B (zh) | 一种改造体抗菌肽及其应用 | |
CN114409800B (zh) | 制备重组胱抑素c的方法 | |
CN110734492B (zh) | 抗f4/80的多克隆抗体及制备方法 | |
CN112266421B (zh) | 一种重组融合蛋白及其制备的预防pcv2病毒感染的疫苗 | |
CN117603332B (zh) | 重组人ny-eso-1蛋白的制备方法及其应用 | |
CN112812156B (zh) | 一种新型冠状病毒covid-19-s1蛋白的表达和纯化方法 | |
CN115873833B (zh) | 生产免疫球蛋白g降解酶的工程菌株和工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200915 Address after: C1102, innovation Plaza, No. 2007, Pingshan Avenue, Liulian community, Pingshan street, Pingshan District, Shenzhen City, Guangdong Province Applicant after: Shenzhen Jingdan Biomedical Technology Co.,Ltd. Applicant after: Jiangxi Jingmeirui Biomedical Co.,Ltd. Address before: C1102, innovation Plaza, No. 2007, Pingshan Avenue, Liulian community, Pingshan street, Pingshan District, Shenzhen City, Guangdong Province Applicant before: Shenzhen Jingdan Biomedical Technology Co.,Ltd. Applicant before: Jiangxi Jingmeirui Biomedical Co.,Ltd. Applicant before: Li Jian Applicant before: Zhang Jin Applicant before: Zhong Fanglin Applicant before: Wan Shuangyan |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200807 |
|
RJ01 | Rejection of invention patent application after publication |